Data is the foundation of modern business strategy and the fuel for AI applications. It drives decision-making, optimizes operations, and creates personalized customer experiences, enabling businesses ...
Data is a company’s most powerful asset. Yet, many businesses cannibalize this valuable asset by selling it to third parties when they should be using it to make their businesses stronger and more ...
Clinical Ink, a pharma-focused mobile clinical trial data collection company, has raised $4.3 million. FCA Venture partners led the round, with additional funding from 10 undisclosed angel investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback